KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oneok (OKE) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Oneok (OKE) over the last 17 years, with Q3 2025 value amounting to $1.2 billion.

  • Oneok's Cash & Equivalents rose 10708.12% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 10708.12%. This contributed to the annual value of $733.0 million for FY2024, which is 11686.39% up from last year.
  • According to the latest figures from Q3 2025, Oneok's Cash & Equivalents is $1.2 billion, which was up 10708.12% from $97.0 million recorded in Q2 2025.
  • Oneok's Cash & Equivalents' 5-year high stood at $1.2 billion during Q3 2025, with a 5-year trough of $14.6 million in Q1 2022.
  • Its 5-year average for Cash & Equivalents is $305.2 million, with a median of $220.0 million in 2022.
  • Per our database at Business Quant, Oneok's Cash & Equivalents crashed by 9636.94% in 2022 and then surged by 455434.63% in 2023.
  • Quarter analysis of 5 years shows Oneok's Cash & Equivalents stood at $146.4 million in 2021, then soared by 50.28% to $220.0 million in 2022, then surged by 53.64% to $338.0 million in 2023, then soared by 116.86% to $733.0 million in 2024, then soared by 63.57% to $1.2 billion in 2025.
  • Its Cash & Equivalents was $1.2 billion in Q3 2025, compared to $97.0 million in Q2 2025 and $141.0 million in Q1 2025.